Similar articles

• Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants.

  Nara M, Takahashi N, Miura M, Niioka T, Kagaya H, Fujishima N, Saitoh H, Kameoka Y, Tagawa H, Hirokawa M, Sawada K. Nara M, et al. Eur J Clin Pharmacol. 2013 Jun;69(6):1321-9. doi: 10.1007/s00228-013-1471-2. Epub 2013 Jan 26. Eur J Clin Pharmacol. 2013. PMID: 23354810 Clinical Trial.
• Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with bioavailability of oral solution itraconazole.

  Mori T, Aisa Y, Kato J, Nakamura Y, Ikeda Y, Okamoto S. Mori T, et al. Int J Hematol. 2009 Jul;90(1):103-107. doi: 10.1007/s12185-009-0344-z. Epub 2009 May 27. Int J Hematol. 2009. PMID: 19472033
• Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients.

  Leather H, Boyette RM, Tian L, Wingard JR. Leather H, et al. Biol Blood Marrow Transplant. 2006 Mar;12(3):325-34. doi: 10.1016/j.bbmt.2005.10.022. Biol Blood Marrow Transplant. 2006. PMID: 16503502 Clinical Trial.
• Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know.

  Leather HL. Leather HL. Bone Marrow Transplant. 2004 Jan;33(2):137-52. doi: 10.1038/sj.bmt.1704316. Bone Marrow Transplant. 2004. PMID: 14676788 Review.
• Clinically significant drug-drug interaction between tacrolimus and fluconazole in stable renal transplant recipient and literature review.

  He J, Yu Y, Yin C, Liu H, Zou H, Ma J, Yang W, Liu Y, Zhong L, Chen X. He J, et al. J Clin Pharm Ther. 2020 Apr;45(2):264-269. doi: 10.1111/jcpt.13075. Epub 2019 Nov 22. J Clin Pharm Ther. 2020. PMID: 31756280 Review.